A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents

Several reviews of inhibitors of topoisomerase II have been published, covering research before 2018. Therefore, this review is focused primarily on more recent publications with relevant points from the earlier literature. Topoisomerase II is an established target for anticancer drugs, which are fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Okoro, Cosmas O., Fatoki, Toluwase Hezekiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916523/
https://www.ncbi.nlm.nih.gov/pubmed/36768852
http://dx.doi.org/10.3390/ijms24032532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916523/
https://www.ncbi.nlm.nih.gov/pubmed/36768852
http://dx.doi.org/10.3390/ijms24032532

Ejemplares similares